NCT04744506View on ClinicalTrials.gov

Targeted Resection of Axillary Metastatic Lymph Nodes After Breast Cancer Neoadjuvant Chemotherapy

NARecruitingINTERVENTIONAL
Enrollment

126

Participants

Timeline

Start Date

November 30, 2024

Primary Completion Date

July 15, 2028

Study Completion Date

July 15, 2029

Conditions
Breast CancerSurgeryLymph Node Metastases
Interventions
DEVICE

Tissue Marker Clip

Tissue Marker Clip to be Placed in Metastatic Axillary Lymph Node (Before Neoadjuvant Chemotherapy for Breast Cancer)

DRUG

Carbon Nanoparticle Suspension Injection

Carbon Nanoparticle Suspension Injection to be Placed in Metastatic Axillary Lymph Node (Before Neoadjuvant Chemotherapy for Breast Cancer)

DRUG

Carbon Nanoparticle Suspension Injection

Carbon Nanoparticle Suspension Injection to be Placed around Primary Tumor (Before Neoadjuvant Chemotherapy for Breast Cancer)

Trial Locations (1)

310000

RECRUITING

2nd Affiliated Hospital, School of Medicine, Zhejiang University, China, Hangzhou

All Listed Sponsors
collaborator

Zhejiang Provincial Natural Science Foundation of China

OTHER

lead

Second Affiliated Hospital, School of Medicine, Zhejiang University

OTHER